Copyright: © 2026 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

OPINION

Legal, clinical, and ethical issues in bioequivalence research

About authors

Yaroslavl State Medical University, Yaroslavl, Russia

Correspondence should be addressed: Elena G. Lileeva
Revolutsionnaya St., 5, Yaroslavl, 150000, Russia; ur.xednay@6002aveelile

About paper

Author contribution: Speshilova SA — selection and analysis of literature, writing the text; Lileeva EG — scientific guidance, methodological support, final editing and approval of the text; Sinitsina OA — selection and analysis of literature, text editing.

Received: 2025-12-11 Accepted: 2026-02-14 Published online: 2026-02-26
|
  1. Bioequivalence Study in Generic Products. Veeprho, 2025. Available from URL: https://veeprho.com/bioequivalence-study-in-generic-products/ (accessed: 11.12.2025).
  2. The Role of Generic Medicines in Sustaining Healthcare Systems. IQVIA Institute Report. Available from URL: https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/the-role-of-generic-medicines-in-sustaining-healthcare-systems.pdf (accessed: 11.12.2025).
  3. Generic medicines — homepage. Medicines for Europe, 2024. Available from URL: https://www.medicinesforeurope.com/generic-medicines/ (data obrashcheniya: 11.12.2025).
  4. Ministerstvo zdravookhraneniya Rossiyskoy Federatsii. Reyestr vydannykh razresheniy na provedeniye klinicheskikh issledovaniy lekarstvennykh preparatov. Available from URL: https://minzdrav.gov.ru/opendata/7707778246-reestrklinicheskihissledovanii/visual (accessed: 11.12.2025).
  5. Klinicheskiye issledovaniya v Rossii i YEAES v 2024 godu: itogi goda i prognozy. ScienceFiles.ru. 10.02.2025. Available from URL: https://sciencefiles.ru/about/news/klinicheskie-issledovaniya-v-rossii-i-eaes-v-2024-godu-itogi-goda-i-prognozy/ (accessed: 11.12.2025).
  6. V Rossii sokratilos' chislo razresheniy na klinicheskiye issledovaniya na chetvert'. Farmatsevticheskiy vestnik. 15.09.2024. Available from URL: https://pharmvestnik.ru/content/news/V-Rossii-sokratilos-chislo-razreshenii-na-klinicheskie-issledovaniya-na-chetvert.html (accessed: 11.12.2025).
  7. Prikaz Minzdrava RF ot 01.04.2016 № 200n «Ob utverzhdenii Pravil nadlezhashchey klinicheskoy praktiki v Rossiyskoy Federatsii». Available from URL: https://www.garant.ru (accessed: 07.12.2025).
  8. GOST R 52379-2005 «Nadlezhashchaya klinicheskaya praktika». Available from URL: https://protect.gost.ru (accessed: 07.12.2025).
  9. Vsemirnaya meditsinskaya assotsiatsiya. Khel'sinkskaya deklaratsiya eticheskikh printsipov meditsinskikh issledovaniy s uchastiyem lyudey (red. 2013). Available from URL: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ (accessed: 07.12.2025).
  10. Prikaz Minzdrava RF ot 31.03.2025 № 157n «Ob utverzhdenii Pravil provedeniya ekspertizy lekarstvennykh sredstv». Available from URL: https://www.garant.ru (data obrashcheniya: 07.12.2025).
  11. Metodicheskiye ukazaniya Minzdrava Rossii po provedeniyu kachestvennykh i kolichestvennykh issledovaniy bioekvivalentnosti lekarstvennykh preparatov dlya meditsinskogo primeneniya ot 10.08.2004 (red. 2024). Available from URL: https://roszdravnadzor.gov.ru (accessed: 07.12.2025).
  12. Resheniye Soveta Yevraziyskoy ekonomicheskoy komissii (YEAEK) ot 3 noyabrya 2016 g. N 79 "Ob utverzhdenii Pravil nadlezhashchey klinicheskoy praktiki Yevraziyskogo ekonomicheskogo soyuza (YEAES)". Available from URL: https://docs.cntd.ru/document/456026110 (accessed: 07.12.2025).
  13. Resheniye Soveta Yevraziyskoy ekonomicheskoy komissii ot 03.11.2016 № 85 «Ob utverzhdenii Pravil provedeniya issledovaniy bioekvivalentnosti lekarstvennykh preparatov v ramkakh YEAES». Available from URL: https://www.alta.ru/tamdoc/16sr0087/ (accessed: 07.12.2025).
  14. GOST R 57679-2017 «Lekarstvennyye sredstva dlya meditsinskogo primeneniya. Issledovaniya bioekvivalentnosti lekarstvennykh preparatov». Available from URL: https://protect.gost.ru (accessed: 07.12.2025).
  15. Zdrav.Expert. Klinicheskiye issledovaniya v Rossii Zdrav.expert. 14 yanv. 2025. Available from URL: https://zdrav.expert/index.php/Stat'ya:Klinicheskiye_issledovaniya_v_Rossii (accessed: 07.12.2025).
  16. Sokolov AA. Pravila issledovaniya bioekvivalentnosti lekarstvennykh preparatov. Zhurnal klinicheskoy farmakokinetiki. 2020; 15(2): 45–58.
  17. Khokhlov A.L., Polozova Ye.A., Komisarova V.A., Chudova N.V., Tsyzman L.G. Riski, sopryazhennyye s eticheskimi aspektami provedeniya klinicheskikh issledovaniy. Kachestvennaya klinicheskaya praktika. 2020; (1): 61-68.
  18. Petrova NN. Issledovaniya bioekvivalentnosti: psikhologicheskiy portret dobrovol'tsa. Meditsinskaya psikhologiya. 2018; 6(4): 30–38.
  19. Smith J, Brown L. Volunteers in bioequivalence clinical trials: premises for participation. Journal of Clinical Research. 2023; 12(2):100–110.
  20. Rukovodstvo po meditsinskoy etike i zashchite personal'nykh dannykh v klinicheskikh issledovaniyakh / pod red. A. A. Sidorova. M.: Meditsinskoye izdatel'stvo, 2024; 120 s.
  21. Opyt provedeniya issledovaniy bioekvivalentnosti lekarstvennykh preparatov. Farmakokinetika i farmakodinamika. 2023;4: 45–52.
  22. Problemy provedeniya bioanaliticheskoy chasti issledovaniy bioekvivalentnosti lekarstvennykh preparatov. CyberLeninka. 2022. Available from URL: cyberleninka.ru (accessed: 11.12.2025).
  23. Dobrovolets na issledovaniya bioekvivalentnosti: prava i obyazannosti. Bioequivalence Trials. 2023. Available from URL: bioequivalencetrials.ru (accessed: 11.12.2025).